Forsyth Barr MST Access initiates coverage on ArborGen

3 February 2026: ArborGen Holdings Limited (NZX: ARB) (ArborGen or the Company) is pleased to announce that Forsyth Barr MST Access has initiated coverage on ArborGen as part of its issuer sponsored research programme. ArborGen believes this research will foster investor understanding of ArborGen’s performance and prospects. Investors can access the initial report and future reports on the Forsyth Barr MST Access website at https://www.forsythbarr.co.nz/research-library/forsyth-barr-mst-research/. The Directors and Management of AborGen accept no responsibility or liability for the analysis, views expressed or recommendations of the Forsyth Barr MST Access team or any other share-broking firms or analysts. ENDS Authority for this announcement: Justin Birch, President and CEO, ArborGen Holdings Limited For more information, please contact: Jackie Ellis, Ellis and Co e: jackie@ellisandco.co.nz, t: +64 27 2462505 ArborGen ArborGen is the leading supplier of advanced genetics seedlings to the global commercial forestry industry. Employing state-of-the-art technology, ArborGen is developing high-value products that significantly improve the productivity of a given acre of land by enabling our customers to grow trees that yield more wood per acre with greater consistency and quality in a shorter period of time. For more information, please visit ArborGen’s website at www.arborgen.com